Sponsored Links
| Interim Study Shows Novel Experimental Agent Is Highly Active In CLL Patients |
 |
 |
 |
| Medical News - Lymphoma and Leukemia | |||
|
An interim analysis of a phase II clinical trial indicates that a novel experimental agent for chronic lymphocytic leukemia (CLL) is highly active and well tolerated both in patients who are undergoing treatment for the first time and those who have relapsed and are resistant to other therapy... Read more: Lymphoma / Leukemia / Myeloma News From Medical News Today
|